Breaking News

CCBR-SYNARC, BioClinica To Merge

Jeffrey McMullen appointed chairman

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

CCBR-SYNARC and BioClinica have signed an agreement to merge, creating a global provider of outsourced clinical services from centers throughout Asia, Europe and The Americas. The combined company will offer a portfolio of services for conducting and managing global clinical trials. The transaction is expected to close in 1Q14. Financial terms were not disclosed.   Jeffrey McMullen, vice chairman of inVentiv Health, Inc., will serve as chairman of the combined company. Mark Weinstein, president ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters